Colon & Colorectal Cancer · Article 155

How Should a Malignant Colorectal Polyp Be Managed?

Malignant colorectal polyp requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Malignant colorectal polyp clinical reference — Related free clinical resource: Images in Gastroenterology and Hepatology.

Malignant colorectal polyp: practical clinical approach

This page focuses on Malignant colorectal polyp with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Malignant colorectal polyp

Clinical takeaway: For Malignant colorectal polyp, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: A malignant colorectal polyp contains invasive adenocarcinoma extending through the muscularis mucosa into the submucosa. Management depends on whether endoscopic resection was oncologically adequate. An en bloc specimen with clear margins, favorable differentiation, no lymphovascular invasion and no other high-risk pathologic features may be considered curatively resected endoscopically. Unfavorable histology, uncertain/positive margins, deep invasion or fragmented specimens generally require multidisciplinary discussion and often oncologic surgical resection with lymph-node assessment.

Pathology determines the next step

The report should address margin status, differentiation, lymphovascular invasion and depth/pattern of submucosal invasion.

En bloc resection matters

Piecemeal removal can make margin and invasion assessment unreliable, which may convert a potentially curative endoscopic resection into an uncertain one.

Rectal lesions deserve special planning

Surgical morbidity and local staging considerations differ, so rectal malignant polyps often require specialized multidisciplinary review.

Practical clinical algorithm

1. Retrieve the specimen intact when invasion is suspected.

2. Request complete malignant-polyp pathology reporting.

3. Classify pathologic features as favorable or unfavorable.

4. Stage appropriately when surgery is being considered.

5. Discuss high-risk lesions with colorectal surgery/oncology.

6. Use surveillance after truly curative endoscopic resection.

Common mistakes to avoid

Calling intramucosal carcinoma a malignant polyp with nodal risk.
Accepting fragmented pathology for a suspected invasive lesion.
Ignoring lymphovascular invasion.
Using a cautery margin alone without full pathology context.
Sending every low-risk malignant polyp automatically to surgery.

Trainee takeaway

Malignant-polyp management is a pathology-and-resection-quality decision: some are cured endoscopically, while high-risk lesions need lymph-node surgery.

Frequently asked questions

What defines a malignant polyp?

Submucosal invasion by adenocarcinoma.

Can endoscopic resection be curative?

Yes, when resection and histology are favorable.

Why does piecemeal resection matter?

It can prevent reliable assessment of margins and depth.

References

1. Thomson ABR. Endoscopy and Diagnostic Imaging. Part I. CAPstone Academic Publishers; 2012.

2. Thomson ABR. Images in Gastroenterology and Hepatology. Part 1. CAPstone Academic Publishers; 2021.

3. Shaukat A, Kaltenbach T, Dominitz JA, et al. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: US Multi-Society Task Force. Gastroenterology. 2020;159:1916-1934.e2.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions